CS logo
small CS logo
Otto-von-Guericke-Universität Magdeburg

Magdeburg, Germany
Public university in Magdeburg, Saxony-Anhalt
Universitätspl. 2, 39106 Magdeburg

About Otto-von-Guericke-Universität Magdeburg


The Otto von Guericke University Magdeburg was founded in 1993 and is one of the youngest universities in Germany. The university in Magdeburg has about 14,000 students in nine faculties. There are 11,700 papers published in international journals from this institute.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Otto-von-Guericke-Universität Magdeburg


During the past decade, Otto-von-Guericke-Universität Magdeburg conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 11 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22004433664411220011220044110022Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
1999-07-01
Completed
430
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
2000-06-01
Unknown status
1,258
Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
2006-01-01
2007-04-01
Completed
98
Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
2005-10-01
2007-04-01
Terminated
50
Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
2006-06-01
Completed
360
Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma
2004-06-01
2010-06-01
Unknown status
30
Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
2006-12-01
2009-08-01
Completed
52
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
2006-12-01
2011-06-01
Terminated
888

Rows per page:

1–51 of 51

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Otto-von-Guericke-Universität Magdeburg" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boston Scientific Corporation" with 4 trials sponsored, "University of Magdeburg" with 4 trials sponsored, "Amgen" with 3 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 34 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Otto-von-Guericke-Universität Magdeburg" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "ICON plc" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAbbott Medical Devices: 4Abbott Medical Devices: 4Boston Scientific Corporation: 4Boston Scientific Corporation: 4University of Magdeburg: 4University of Magdeburg: 4Amgen: 3Amgen: 3Stichting Hemato-Oncologie voorVolwassenenNederland: 3Stichting Hemato-Oncologie voorVolwassenenNederland: 3Biotronik SE & Co. KG: 2Biotronik SE & Co. KG: 2C. R. Bard: 2C. R. Bard: 2European Organisationfor Research andTreatment of Cancer -EORTC: 2European Organisationfor Research andTreatment of Cancer -EORTC: 2Johannes GutenbergUniversity Mainz: 2Johannes GutenbergUniversity Mainz: 2Ataxia Study Group: 1Ataxia Study Group: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbott: 2Abbott: 2Deutsch-ÖsterreichischeStudiengruppe AkuteMyeloische Leukämie(AMLSG): 2Deutsch-ÖsterreichischeStudiengruppe AkuteMyeloische Leukämie(AMLSG): 2ICON plc: 2ICON plc: 2Astellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma GlobalDevelopment, Inc.: 1Bayer: 1Bayer: 1Biocompatibles UK Ltd: 1Biocompatibles UK Ltd: 1Deutsche Herzstiftung e.V.: 1Deutsche Herzstiftung e.V.: 1Deutsche Krebshilfee.V., Bonn (Germany):1Deutsche Krebshilfee.V., Bonn (Germany):1Deutsches Zentrum fürHerz-Kreislauf-Forschung (DZHK): 1Deutsches Zentrum fürHerz-Kreislauf-Forschung (DZHK): 1Eli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at Otto-von-Guericke-Universität Magdeburg


According to Clinical.Site data, the most researched conditions in "Otto-von-Guericke-Universität Magdeburg" are "Colorectal Cancer" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Heart Failure" (2 trials), "Hepatocellular Carcinoma" (2 trials) and "Mitral Regurgitation" (2 trials). Many other conditions were trialed in "Otto-von-Guericke-Universität Magdeburg" in a lesser frequency.

Clinical Trials Intervention Types at Otto-von-Guericke-Universität Magdeburg


Most popular intervention types in "Otto-von-Guericke-Universität Magdeburg" are "Drug" (22 trials), "Device" (17 trials), "Procedure" (7 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Evolocumab" (2 trials), "Irinotecan" (2 trials), "Midostaurin" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Otto-von-Guericke-Universität Magdeburg


The vast majority of trials in "Otto-von-Guericke-Universität Magdeburg" are 49 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Otto-von-Guericke-Universität Magdeburg


Currently, there are NaN active trials in "Otto-von-Guericke-Universität Magdeburg". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Otto-von-Guericke-Universität Magdeburg, undefined suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Otto-von-Guericke-Universität Magdeburg, 6 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 15Phase 2: 15Phase 3: 13Phase 3: 13Not Applicable: 10Not Applicable: 10Phase 1: 6Phase 1: 6Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 25Completed: 25Terminated: 9Terminated: 9Active, not recruiting: 7Active, not recruiting: 7Recruiting: 7Recruiting: 7Unknown status: 3Unknown status: 3

Departments of Otto-von-Guericke-Universität Magdeburg


Otto-von-Guericke-Universität Magdeburg has several departments that took part in Clinical trials: "Inst. f. Medical Psychology, Univ. of Magdeburg" - 10 trials, "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie" - 4 trials, "Universitätsklinikum Magdeburg / Institut für Kognitive Neurologie und Demenzforschung" - 3 trials, "Neurologische Klinik der Otto-von-Guericke-Universität" - 3 trials, "Universitätsklinikum Magdeburg Klinik für Gastroenterologie und Hepatologie" - 2 trials, "Universitätsklinikum Magdeburg A. ö. R., Kinderklinik, Päd. Hämatologie / Onkologie" - 2 trials, "Universitätsklinikum Magdeburg Klinik für Kardiologie Angiologie u.Pneumologie" - 2 trials, "Otto-von-Guericke-Universität Magdeburg Universitätsklinik für Neuroradiologie" - 2 trials, "Universitätsklinikum Magdeburg; Hautklinik; Klinik für Dermatologie und Venerologie" - 2 trials